Lipe & Dalton Has $4.94 Million Position in Danaher Co. (NYSE:DHR)

Lipe & Dalton reduced its holdings in shares of Danaher Co. (NYSE:DHR) by 0.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 21,523 shares of the conglomerate’s stock after selling 130 shares during the quarter. Danaher accounts for 2.6% of Lipe & Dalton’s holdings, making the stock its 11th biggest position. Lipe & Dalton’s holdings in Danaher were worth $4,941,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently bought and sold shares of the business. Redmond Asset Management LLC grew its holdings in Danaher by 90.7% during the 4th quarter. Redmond Asset Management LLC now owns 12,737 shares of the conglomerate’s stock worth $2,924,000 after acquiring an additional 6,058 shares during the period. Prentice Wealth Management LLC grew its holdings in Danaher by 6.5% during the 4th quarter. Prentice Wealth Management LLC now owns 2,834 shares of the conglomerate’s stock worth $651,000 after acquiring an additional 172 shares during the period. Ipswich Investment Management Co. Inc. boosted its position in shares of Danaher by 1.4% during the 4th quarter. Ipswich Investment Management Co. Inc. now owns 6,092 shares of the conglomerate’s stock worth $1,398,000 after purchasing an additional 84 shares in the last quarter. Greystone Financial Group LLC boosted its position in shares of Danaher by 39.1% during the 4th quarter. Greystone Financial Group LLC now owns 47,810 shares of the conglomerate’s stock worth $10,975,000 after purchasing an additional 13,443 shares in the last quarter. Finally, VisionPoint Advisory Group LLC bought a new position in shares of Danaher during the 4th quarter worth about $69,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms have recently issued reports on DHR. Wells Fargo & Company cut their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Royal Bank of Canada reissued an “outperform” rating and set a $277.00 price objective (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Raymond James reissued a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a research report on Thursday, October 31st. Finally, Guggenheim assumed coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price objective for the company. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Stock Performance

NYSE DHR opened at $209.86 on Friday. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a market capitalization of $151.58 billion, a P/E ratio of 39.75, a P/E/G ratio of 2.61 and a beta of 0.83. The company has a fifty day moving average of $226.71 and a 200-day moving average of $247.11.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm earned $2.09 earnings per share. As a group, equities research analysts predict that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.32 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.61%. Danaher’s payout ratio is currently 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.